MS: Busting the Myths
May 26, 2021 | Advocacy
Multiple Sclerosis NZ received several reports from concerned patients regarding the ambiguity of the Special Authority Criteria for DMTs. With the support of Dr John Mottershead, Pharmac were approached for clarification. Concern centred around whether bilateral aids qualify for use […]
May 25, 2021 | Advocacy, Media
Still unfunded, but finally acknowledged, McDonald 2017 criteria for diagnosing Multiple Sclerosis (MS) is one step closer to being used in NZ for accessing treatment. The February 2021 minutes of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) were released this month, recommending […]
May 25, 2021 | Media
The vast majority of New Zealanders believe people working in community support roles are important to society but less than half of New Zealanders would recommend it to family as a career, according to new research. Yet, it’s a hugely […]
May 20, 2021 | Advocacy, Media, Treatments
Anne Beasley had to travel to India for Hematopoietic Stem Cell Transplant (HSCT) at the end of 2019 and at a cost of $42,000 Although it is already available in New Zealand for people with blood and bone marrow cancer, […]
May 19, 2021 | Covid-19, Event
About this event The New Zealand Covid Vaccine Programme is currently being rolled out and will soon be available for those with disabilities and high-risk health concerns. We acknowledge the high level of interest within the Multiple Sclerosis (MS) […]